Abstract
Hypertension and hypercholesterolemia are two main physiological risk factors of cardiovascular disease, and commonly occur in combination. Multicompound combination therapy is rational for the treatment of concurrent hypertension and hypercholesterolemia, while telmisartan and pitavastatin calcium can be used as a potential drug combination. The aim of this paper is to study the intestinal absorption and absorption interaction of telmisartan and pitavastatin calcium. An HPLC method was developed and validated to determine telmisartan and pitavastatin calcium in intestinal perfusate simultaneously. The in situ single-pass perfusion in rats was utilized to investigate the effects of concentrations, intestinal segment (duodenum, jejunum, ileum and colon) and co-administrated drugs on absorption. The effective permeability coefficient and the absorption rate constant of telmisartan were higher in the duodenum as compared to other intestinal segments. However, the intestinal absorption of pitavastatin calcium was not segmental dependent. The effective permeability coefficient and absorption rate constant have no significant difference among three concentrations of telmisartan, pitavastatin calcium individually and their combination...Continue Reading
References
Feb 1, 1986·Journal of Pharmaceutical Sciences·N SchurgersD J Crommelin
Sep 1, 1996·Pharmaceutical Research·U FagerholmH Lennernäs
Mar 7, 2001·Hypertension·M Rodriguez-PorcelL O Lerman
Mar 19, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Debbie TamK Sandy Pang
Jun 28, 2003·BMJ : British Medical Journal·N J Wald, M R Law
Feb 1, 2005·Lancet·Rod JacksonAnthony Rodgers
Nov 26, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Arik DahanGordon L Amidon
Feb 28, 2009·Molecular Pharmaceutics·Arik Dahan, Gordon L Amidon
Feb 12, 2010·The Journal of International Medical Research·M Burnier
May 8, 2010·Vascular Health and Risk Management·Domenico GalzeranoCarlo Gaudio
Jan 5, 2011·Atherosclerosis. Supplements·John Betteridge
Mar 31, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pedro Marques da Silva
Jul 13, 2012·Circulation. Cardiovascular Quality and Outcomes·Salim YusufKoon K Teo
Mar 29, 2014·European Journal of Preventive Cardiology·Anushka PatelUNKNOWN Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration
Apr 23, 2014·Annals of Global Health·Brandon Wiley, Valentin Fuster
Jan 1, 2012·The Cochrane Database of Systematic Reviews·Angharad N de CatesMark Huffman
May 30, 2015·Korean Circulation Journal·Ji-Yong JangYangsoo Jang
Jun 10, 2015·European Journal of Pharmacology·Cuihuan XuXiangrong Song
Jun 24, 2015·Fitoterapia·Xiao-Yan ZengYu-Feng Xia
Sep 27, 2015·Circulation·Gregory A RothChristopher J L Murray
Jun 4, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Michel E BertrandJean-Jacques Mourad